XP Chemistries AB (publ) (XPC.ST)
Sundsvall, SE
As a biotechnology company, XP Chemistries AB specializes in the development and production of forest-derived capsaicin and its related compounds. Its diverse offerings include ingredients for animal nutrition, components for cosmetic formulations, high-purity capsaicinoids, and active agents for self-defense products. Founded in 2018, the Swedish firm operates from its base in Sundsvall.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +1.10% | +1.38% | +10.88% | -0.27% | -2.39% | +0.55% | -28.59% | -71.77% | -95.39% | -95.39% | -95.39% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
-
Revenue growth Chemicals: +4.0%+15.3% ★ Q1'26: +29.5% (vs Q1'25)
-
EPS growth Chemicals: +11.7%+36.8% ★ Q1'26: -3.1% (vs Q1'25)
-
FCF margin FCF growth · Chemicals: +41.7%-2,173.7% Q1'26: -2,203.6% (vs Q1'25)
-
EBIT margin Chemicals: +7.1%-3,224.3% Q1'26: -2,304.6% (vs Q1'25)
-
ROIC Chemicals: +3.4%-48.6% Q1'26: -44.7% (vs Q1'25)
-
Share dilution Chemicals: +0.0%+88.9% Q1'26: +76.4% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Chemicals: 0.55×0.00× Q1'26: 0.00× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 1 Rev. Ana. 1 EPS Ana. |
Dec 2027 1 Rev. Ana. 1 EPS Ana. |
Dec 2028 1 Rev. Ana. 1 EPS Ana. |
Dec 2029 1 Rev. Ana. |
Dec 2030 1 Rev. Ana. |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
279.4K
est: 296.0K (-5.6%)
|
1.06M
est: 1.25M (-15.8%)
|
663.7K
est: 6.39M (-89.6%)
|
283.9K
est: 495.0K (-42.6%)
|
327.4K
est: 410.0K (-20.1%)
|
6.03M
6.03M – 6.03M
+1,371.0% YoY
|
35.58M
35.58M – 35.58M
+490.0% YoY
|
66.37M
66.37M – 66.37M
+86.5% YoY
|
111.51M
111.51M – 111.51M
+68.0% YoY
|
133.81M
133.81M – 133.81M
+20.0% YoY
|
| EBITDA |
-5.01M
est: -296.0K (-1,594.0%)
|
-8.73M
est: -1.25M (-596.5%)
|
-8.70M
est: -6.39M (-36.1%)
|
-7.52M
est: -495.0K (-1,418.3%)
|
-9.05M
est: -410.0K (-2,106.2%)
|
-6.03M
-6.03M – -6.03M
-1,371.0% YoY
|
-35.58M
-35.58M – -35.58M
-490.0% YoY
|
-66.37M
-66.37M – -66.37M
-86.5% YoY
|
-111.51M
-111.51M – -111.51M
-68.0% YoY
|
-133.81M
-133.81M – -133.81M
-20.0% YoY
|
| EBIT |
-5.24M
est: -296.0K (-1,669.9%)
|
-9.86M
est: -1.25M (-686.1%)
|
-10.11M
est: -6.39M (-58.2%)
|
-8.93M
est: -495.0K (-1,703.6%)
|
-10.56M
est: -410.0K (-2,474.7%)
|
-6.03M
-6.03M – -6.03M
-1,371.0% YoY
|
-35.58M
-35.58M – -35.58M
-490.0% YoY
|
-66.37M
-66.37M – -66.37M
-86.5% YoY
|
-111.51M
-111.51M – -111.51M
-68.0% YoY
|
-133.81M
-133.81M – -133.81M
-20.0% YoY
|
| Net Income |
-4.55M
est: -8.31M (+45.3%)
|
-7.92M
est: -16.63M (+52.4%)
|
-8.04M
est: -24.94M (+67.8%)
|
-7.13M
est: -11.62M (+38.6%)
|
-8.52M
est: -6.76M (-26.0%)
|
-6.36M
-6.36M – -6.36M
+5.9% YoY
|
-1.79M
-1.79M – -1.79M
+71.9% YoY
|
3.78M
3.78M – 3.78M
+311.1% YoY
|
—
— – —
-100.0% YoY
|
—
— – —
|
| SGA |
3.73M
est: 4.13M (-9.7%)
|
9.04M
est: 17.49M (-48.3%)
|
—
est: 89.12M (-100.0%)
|
7.87M
est: 4.91M (+60.2%)
|
—
est: 4.07M (-100.0%)
|
59.83M
59.83M – 59.83M
+1,371.0% YoY
|
353.03M
353.03M – 353.03M
+490.0% YoY
|
658.49M
658.49M – 658.49M
+86.5% YoY
|
1.11B
1.11B – 1.11B
+68.0% YoY
|
1.33B
1.33B – 1.33B
+20.0% YoY
|
| EPS |
-0.30
est: -0.08 (-280.0%)
|
-0.26
est: -0.16 (-64.7%)
|
-0.26
est: -0.24 (-9.8%)
|
-0.07
est: -0.06 (-15.9%)
|
-0.04
est: -0.03 (-25.9%)
|
-0.03
-0.03 – -0.03
+5.9% YoY
|
-0.01
-0.01 – -0.01
+71.9% YoY
|
0.02
0.02 – 0.02
+311.1% YoY
|
—
— – —
-100.0% YoY
|
—
— – —
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | C | 2/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-28 | C | 2/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-27 | C | 2/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-26 | C | 2/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-25 | C | 2/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-22 | C | 2/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-21 | C | 2/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-20 | C | 2/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-19 | C | 2/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-18 | C | 2/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-15 | C | 2/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-13 | C | 2/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-12 | C | 2/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-11 | C | 2/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-08 | C | 2/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-07 | C | 2/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-06 | C | 2/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-05 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-04 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-30 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-29 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-28 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-27 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-24 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-23 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-22 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-21 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-20 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-17 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-16 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Erik Nelsson | Chief Executive Officer & MD | 1M | male |
| Anders Frejdh | Chief Financial Officer | — | male |
| Shuangzheng Lin | Chief Technology Officer | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for XPC.ST
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
